abstract |
The present invention is directed to selective estrogen receptor modulators (SERMs) and methods for their preparation, their use for the treatment and / or prevention of disorders, and more particularly for the treatment of bleeding disorders, osteoporosis, endometriosis, myomas, hormone-dependent tumors. And / or use thereof in the manufacture of a medicament for prophylaxis, hormone replacement therapy and contraception. |